Auxly Cannabis Group Inc. (XLY.TO)
CAD 0.09
(0.0%)
CAD 0.09
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 142.88 Million CAD | -20.16% |
| 2022 | 178.95 Million CAD | 2.06% |
| 2021 | 175.35 Million CAD | 69.47% |
| 2020 | 103.47 Million CAD | 86.13% |
| 2019 | 55.58 Million CAD | 147.29% |
| 2018 | -117.55 Million CAD | -694.11% |
| 2017 | -14.8 Million CAD | -4725.1% |
| 2016 | -306.8 Thousand CAD | 45.86% |
| 2015 | -566.71 Thousand CAD | -6.06% |
| 2014 | -534.31 Thousand CAD | -3.56% |
| 2013 | -515.96 Thousand CAD | -18.55% |
| 2012 | -435.23 Thousand CAD | -21.28% |
| 2011 | -358.88 Thousand CAD | -35.72% |
| 2010 | -264.42 Thousand CAD | -52.5% |
| 2009 | -173.39 Thousand CAD | -66.07% |
| 2008 | -104.41 Thousand CAD | -29.17% |
| 2007 | -80.83 Thousand CAD | -100.07% |
| 2006 | 110.83 Million CAD | -11.96% |
| 2005 | 125.89 Million CAD | 39.67% |
| 2004 | 90.13 Million CAD | 74.26% |
| 2003 | 51.72 Million CAD | 12.5% |
| 2002 | 45.97 Million CAD | 4.61% |
| 2001 | 43.95 Million CAD | -11.14% |
| 2000 | 49.46 Million CAD | 10.84% |
| 1999 | 44.62 Million CAD | 82.5% |
| 1998 | 24.45 Million CAD | 25.77% |
| 1997 | 19.44 Million CAD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 64.39 Million CAD | -5.22% |
| 2024 Q1 | 67.94 Million CAD | -52.45% |
| 2023 Q3 | 147.56 Million CAD | -19.54% |
| 2023 FY | 142.88 Million CAD | -20.16% |
| 2023 Q2 | 183.4 Million CAD | 4.22% |
| 2023 Q4 | 142.88 Million CAD | -3.18% |
| 2023 Q1 | 175.98 Million CAD | -1.66% |
| 2022 Q3 | 177.5 Million CAD | 2.08% |
| 2022 Q4 | 178.95 Million CAD | 0.82% |
| 2022 FY | 178.95 Million CAD | 2.06% |
| 2022 Q2 | 173.88 Million CAD | -3.37% |
| 2022 Q1 | 179.95 Million CAD | 2.63% |
| 2021 Q1 | 106.93 Million CAD | 3.34% |
| 2021 FY | 175.35 Million CAD | 69.47% |
| 2021 Q4 | 175.35 Million CAD | 123.88% |
| 2021 Q3 | 78.32 Million CAD | -4.34% |
| 2021 Q2 | 81.87 Million CAD | -23.43% |
| 2020 Q1 | 77.67 Million CAD | 39.72% |
| 2020 Q4 | 103.47 Million CAD | 2.11% |
| 2020 Q2 | 87.26 Million CAD | 12.36% |
| 2020 Q3 | 101.33 Million CAD | 16.12% |
| 2020 FY | 103.47 Million CAD | 86.13% |
| 2019 FY | 55.58 Million CAD | 147.29% |
| 2019 Q2 | -17.89 Million CAD | 72.28% |
| 2019 Q3 | 17.11 Million CAD | 195.65% |
| 2019 Q1 | -64.56 Million CAD | 45.08% |
| 2019 Q4 | 55.58 Million CAD | 224.78% |
| 2018 Q1 | -115.29 Million CAD | -678.86% |
| 2018 Q3 | -143.59 Million CAD | 29.05% |
| 2018 FY | -117.55 Million CAD | -694.11% |
| 2018 Q4 | -117.55 Million CAD | 18.13% |
| 2018 Q2 | -202.39 Million CAD | -75.54% |
| 2017 Q4 | -14.8 Million CAD | -5835.1% |
| 2017 FY | -14.8 Million CAD | -4725.1% |
| 2017 Q3 | -249.42 Thousand CAD | 98.82% |
| 2017 Q2 | -21.19 Million CAD | -779.28% |
| 2017 Q1 | -2.41 Million CAD | -685.68% |
| 2016 Q2 | -644.92 Thousand CAD | 0.3% |
| 2016 Q1 | -646.89 Thousand CAD | -14.15% |
| 2016 Q4 | -306.8 Thousand CAD | 55.81% |
| 2016 FY | -306.8 Thousand CAD | 45.86% |
| 2016 Q3 | -694.28 Thousand CAD | -7.65% |
| 2015 Q3 | -552.92 Thousand CAD | -1.85% |
| 2015 Q1 | -538.91 Thousand CAD | -0.86% |
| 2015 FY | -566.71 Thousand CAD | -6.06% |
| 2015 Q2 | -542.88 Thousand CAD | -0.74% |
| 2015 Q4 | -566.71 Thousand CAD | -2.49% |
| 2014 FY | -534.31 Thousand CAD | -3.56% |
| 2014 Q4 | -534.31 Thousand CAD | -3.78% |
| 2014 Q2 | -504.36 Thousand CAD | 3.0% |
| 2014 Q3 | -514.83 Thousand CAD | -2.08% |
| 2014 Q1 | -519.95 Thousand CAD | -0.77% |
| 2013 Q4 | -515.96 Thousand CAD | -2.91% |
| 2013 FY | -515.96 Thousand CAD | -18.55% |
| 2013 Q3 | -501.36 Thousand CAD | -9.1% |
| 2013 Q2 | -459.56 Thousand CAD | -2.92% |
| 2013 Q1 | -446.54 Thousand CAD | -2.6% |
| 2012 Q4 | -435.23 Thousand CAD | -17.46% |
| 2012 Q1 | -392.41 Thousand CAD | -9.34% |
| 2012 Q2 | -368.25 Thousand CAD | 6.16% |
| 2012 FY | -435.23 Thousand CAD | -21.28% |
| 2012 Q3 | -370.54 Thousand CAD | -0.62% |
| 2011 Q2 | -289.4 Thousand CAD | -17.4% |
| 2011 Q3 | -106.66 Thousand CAD | 63.14% |
| 2011 Q4 | -358.88 Thousand CAD | -236.47% |
| 2011 FY | -358.88 Thousand CAD | -35.72% |
| 2011 Q1 | -246.51 Thousand CAD | 6.77% |
| 2010 Q1 | -179.05 Thousand CAD | -3.27% |
| 2010 Q2 | -173.89 Thousand CAD | 2.88% |
| 2010 Q3 | -230.59 Thousand CAD | -32.61% |
| 2010 Q4 | -264.42 Thousand CAD | -14.67% |
| 2010 FY | -264.42 Thousand CAD | -52.5% |
| 2009 FY | -173.39 Thousand CAD | -66.07% |
| 2009 Q2 | -107.28 Thousand CAD | 12.06% |
| 2009 Q1 | -121.99 Thousand CAD | -16.84% |
| 2009 Q4 | -173.39 Thousand CAD | -24.44% |
| 2009 Q3 | -139.33 Thousand CAD | -29.88% |
| 2008 FY | -104.41 Thousand CAD | -29.17% |
| 2008 Q1 | -79.83 Thousand CAD | 1.24% |
| 2008 Q2 | -42.96 Thousand CAD | 46.18% |
| 2008 Q3 | -81.42 Thousand CAD | -89.51% |
| 2008 Q4 | -104.41 Thousand CAD | -28.23% |
| 2007 Q2 | 99.46 Million CAD | -10.26% |
| 2007 Q1 | 110.84 Million CAD | 0.01% |
| 2007 Q4 | -80.83 Thousand CAD | -100.1% |
| 2007 Q3 | 78.45 Million CAD | -21.13% |
| 2007 FY | -80.83 Thousand CAD | -100.07% |
| 2006 Q3 | 119.37 Million CAD | -8.78% |
| 2006 Q4 | 110.83 Million CAD | -7.15% |
| 2006 Q2 | 130.85 Million CAD | 0.66% |
| 2006 Q1 | 129.99 Million CAD | 3.26% |
| 2006 FY | 110.83 Million CAD | -11.96% |
| 2005 Q3 | 100.21 Million CAD | 1.95% |
| 2005 Q1 | 96.28 Million CAD | 6.82% |
| 2005 Q4 | 125.89 Million CAD | 25.62% |
| 2005 FY | 125.89 Million CAD | 39.67% |
| 2005 Q2 | 98.3 Million CAD | 2.1% |
| 2004 Q2 | 66.28 Million CAD | 14.85% |
| 2004 Q3 | 68.85 Million CAD | 3.87% |
| 2004 Q4 | 90.13 Million CAD | 30.91% |
| 2004 FY | 90.13 Million CAD | 74.26% |
| 2004 Q1 | 57.71 Million CAD | 11.58% |
| 2003 FY | 51.72 Million CAD | 12.5% |
| 2003 Q4 | 51.72 Million CAD | 8.12% |
| 2003 Q2 | 46.94 Million CAD | 1.04% |
| 2003 Q3 | 47.84 Million CAD | 1.91% |
| 2003 Q1 | 46.46 Million CAD | 1.05% |
| 2002 Q2 | 45.23 Million CAD | 2.62% |
| 2002 FY | 45.97 Million CAD | 4.61% |
| 2002 Q4 | 45.97 Million CAD | 0.62% |
| 2002 Q3 | 45.69 Million CAD | 1.0% |
| 2002 Q1 | 44.08 Million CAD | 0.3% |
| 2001 Q2 | 42.92 Million CAD | -13.56% |
| 2001 Q1 | 49.66 Million CAD | 0.4% |
| 2001 Q3 | 43 Million CAD | 0.18% |
| 2001 FY | 43.95 Million CAD | -11.14% |
| 2001 Q4 | 43.95 Million CAD | 2.2% |
| 2000 Q3 | 44.19 Million CAD | -2.45% |
| 2000 FY | 49.46 Million CAD | 10.84% |
| 2000 Q1 | 45.2 Million CAD | 1.3% |
| 2000 Q4 | 49.46 Million CAD | 11.93% |
| 2000 Q2 | 45.3 Million CAD | 0.22% |
| 1999 Q3 | 41.76 Million CAD | 57.33% |
| 1999 Q2 | 26.54 Million CAD | -1.5% |
| 1999 Q4 | 44.62 Million CAD | 6.84% |
| 1999 FY | 44.62 Million CAD | 82.5% |
| 1999 Q1 | 26.95 Million CAD | 0.0% |
| 1998 FY | 24.45 Million CAD | 25.77% |
| 1998 Q2 | 25.4 Million CAD | -1.17% |
| 1998 Q1 | 25.7 Million CAD | 27.19% |
| 1997 Q4 | 20.21 Million CAD | 0.0% |
| 1997 FY | 19.44 Million CAD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Aurora Cannabis Inc. | -8.64 Million CAD | 1752.174% |
| Avicanna Inc. | 1.32 Million CAD | -10673.647% |
| Avant Brands Inc. | 17.93 Million CAD | -696.877% |
| Cardiol Therapeutics Inc. | -34.77 Million CAD | 510.891% |
| Crescita Therapeutics Inc. | -8.13 Million CAD | 1857.225% |
| Knight Therapeutics Inc. | 10.33 Million CAD | -1283.156% |
| MediPharm Labs Corp. | -15.68 Million CAD | 1010.876% |
| OrganiGram Holdings Inc. | -33.7 Million CAD | 523.863% |
| Canopy Growth Corporation | 512.87 Million CAD | 72.141% |
| Willow Biosciences Inc. | -989 Thousand CAD | 14546.916% |